Quick answer
Bio-Rad Laboratories, Inc. (BIO) reported revenue of $2.58B and net income of $759.9M for the fiscal year ended 2025-12-31, up 0.7% from $2.57B the year before, per its 10-K filed with the SEC on 2026-02-13. Long-term debt stood at $1.20B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $2.58B | $759.9M | $1.20B |
| 2024 (FY ending 2024-12-31) | $2.57B | -$1.84B | $1.20B |
| 2023 (FY ending 2023-12-31) | $2.67B | -$637.3M | $1.21B |
| 2022 (FY ending 2022-12-31) | $2.80B | -$3.63B | $1.20B |
| 2021 (FY ending 2021-12-31) | $2.92B | $4.25B | — |
| 2020 (FY ending 2020-12-31) | $2.55B | $3.81B | — |
| 2019 (FY ending 2019-12-31) | $2.31B | $1.76B | — |
| 2018 (FY ending 2018-12-31) | $2.29B | $365.6M | — |
| 2017 (FY ending 2017-12-31) | $2.16B | $122.2M | — |
| 2016 (FY ending 2016-12-31) | $2.07B | $26.0M | — |
Frequently asked questions
What is Bio-Rad Laboratories, Inc.'s annual revenue?
Bio-Rad Laboratories, Inc. (BIO) reported revenue of $2.58B and net income of $759.9M for the fiscal year ended 2025-12-31, up 0.7% from $2.57B the year before, per its 10-K filed with the SEC on 2026-02-13. Long-term debt stood at $1.20B.
What is BIO's profit margin?
Bio-Rad Laboratories, Inc.'s net margin was 29.4% in the fiscal year ended 2025-12-31.
Related
- BEN revenue, net income and debt history (Franklin Resources Inc)
- BG revenue, net income and debt history (Bunge Global Sa)
- BIIB revenue, net income and debt history (Biogen Inc.)
- BJ revenue, net income and debt history (Bj’S Wholesale Club Holdings, Inc.)
- BKR revenue, net income and debt history (Baker Hughes Company)
- BLK revenue, net income and debt history (BlackRock, Inc.)
- BMNR revenue, net income and debt history (Bitmine Immersion Technologies, Inc.)
- BMRN revenue, net income and debt history (Biomarin Pharmaceutical Inc)
Last updated Oct 18, 2026, 10:02 PM ET. Data only, not financial or tax advice.